Gust Bardy
Clinical Cardiac Electrophysiology Seattle, WA Medical Doctor
NPI 1063533115 CMS profile 848902
1959 Ne Pacific St, Division Of Cardiology, Univ. Of Washington, Box 356422, Seattle, WA 98195
General payments
$130,728,739
Research payments
$0
Ownership & investment interest
$38,934,606
Through program year 2024, Gust Bardy of Seattle, WA is reported in the CMS Open Payments database as having received $130,728,739 across 25 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $38,934,606 across 2 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $480,765 | 1 | |
| 2023 | General | $4,507,382 | 4 | |
| 2022 | General | $3,247,676 | 3 | |
| 2021 | General | $114,616,028 | 6 | |
| 2020 | General | $3,678,469 | 6 | |
| 2019 | General | $4,198,419 | 5 | |
| 2020 | Ownership | $20,504,758 | 1 | |
| 2019 | Ownership | $18,429,848 | 1 |
Beside peers
- Gust Bardy
- Clinical Cardiac Electrophysiology median
- Middle half of Clinical Cardiac Electrophysiology
- National median
In program year 2025, general payments to Gust Bardy were reported at $0. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.
Show as a table
| Year | Gust Bardy | Clinical Cardiac Electrophysiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $4,198,419 | $2,361 | $585–$8,260 | $163 |
| 2020 | $3,678,469 | $993 | $247–$4,351 | $114 |
| 2021 | $114,616,028 | $1,185 | $326–$4,739 | $132 |
| 2022 | $3,247,676 | $2,073 | $554–$6,789 | $149 |
| 2023 | $4,507,382 | $2,568 | $759–$8,159 | $160 |
| 2024 | $480,765 | $2,557 | $703–$7,403 | $164 |
| 2025 | $0 | $2,462 | $733–$7,710 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
25 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Cardiac Electrophysiology in Washington
Babak Nazer
Clinical Cardiac Electrophysiology · Seattle, WA
Maheer Gandhavadi
Clinical Cardiac Electrophysiology · Bellevue, WA
Toshimasa Okabe
Clinical Cardiac Electrophysiology · Seattle, WA
Darryl Wells
Clinical Cardiac Electrophysiology · Seattle, WA
Arun R Mahankali Sridhar
Clinical Cardiac Electrophysiology · Seattle, WA
Jeanne Poole
Clinical Cardiac Electrophysiology · Seattle, WA
Related records
Clinical Cardiac Electrophysiology in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Cardiac Electrophysiology
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.